HOME >> MEDICINE >> NEWS
Emory University will conduct clinical trial of anthrax vaccine regimen

Emory University is one of five sites nationwide selected by the Centers for Disease Control and Prevention (CDC) to conduct a clinical trial of an anthrax vaccination regimen. The study, which is now enrolling volunteers, will use the anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA) in 1970. The new trial is designed to test whether changing the injection method from subcutaneous (under the skin) to the muscle or decreasing the number of doses affects the quality of the immune response or local reactions to the vaccine.

Harry Keyserling, M.D., professor of pediatric infectious diseases at Emory University School of Medicine, is principal investigator for the Emory study. Other sites include Baylor College of Medicine; the Mayo Clinic; the University of Alabama at Birmingham; and Walter Reed Army Medical Center.

Anthrax is a disease caused by the Bacillus anthracis germ, and most often is found in cattle and sheep. Infection with anthrax bacteria may cause skin sores and intestinal or lung illness. Intestinal or lung illness is often serious and may be fatal. Individuals become infected with anthrax when they eat or touch animal parts that contain the bacteria or when they eat, touch or breathe bacteria in the air or on the ground.

The last human clinical trials of the anthrax vaccine were conducted in the 1950s in goat mill workers and in the laboratory scientists who studied anthrax. In 1991, with the threat of Iraqi bioweapons during the Persian Gulf War, the US military began vaccinating soldiers headed to the Persian Gulf. A shortage of vaccine and an exhaustive vaccination schedule that stretched over several years required many soldiers to complete their anthrax immunizations on the battlefield. In 1998, after assessing the threat of biological weapons, the Department of Defense required all U.S. armed forces to receive the anthrax vaccine. More than two million people, mostly in the military, hav
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
14-May-2002


Page: 1 2 3

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory researchers find race and gender gaps in treatment of heart attack
7. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
8. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
9. Emory scientists find marker for long-term immunity
10. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
11. Emory scientists link atrial fibrillation with decrease in nitrous oxide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch was ... most people would. Rather than become melancholic, however, he put together a final lecture ... dreams. Randy Pausch took a negative situation and turned it into something that inspired ...
(Date:8/28/2020)... ... 2020 , ... WHAT , Hespiro™ is a new type ... including COVID-19, while reducing the need for scarce mechanical ventilators. It not only ... scrubs it free of carbon dioxide in a completely closed “rebreather” system, important ...
(Date:8/28/2020)... DOWNERS GROVE, Ill. (PRWEB) , ... August 28, ... ... to COVID-19, The Nourished Group set out to continue helping the ... , attendees can discover new gluten-free products, get coupons, enter giveaways, chat with ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... role in advising Adventist Health on its investment in Synchronous Health, a tech-enabled ... company that combines the strength of human empathy with artificial intelligence (AI) to ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... ... has joined the Walk-in Dermatology team in its Greenvale, New York location. ... Nail and Skin Care Institute. She is certified in chemical peels, microdermabrasion, Hydrafacial ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... , ... Bleep LLC, maker of the DreamPort mask-less CPAP solution, announced today ... spokesperson. , “In my line of work, a good night of sleep is critical ... was a Bleeping no brainer for me,” said Jensen. “From the moment I started ...
(Date:8/26/2020)... ... 26, 2020 , ... AseptiScope, a privately funded San Diego, California based, clinical ... MedTech Outlook. , “AseptiScope is pleased to receive this recognition,” said Kelly ... gloves on their hands, goggles on their eyes, covers on their shoes, and gowns ...
(Date:8/26/2020)... ... August 26, 2020 , ... Crossroads Hospice ... added CHC and CPCO to her name. , That’s thanks to her completion ... and the Certified Professional Compliance Officer (CPCO.) , The CHC is designed to ...
Breaking Medicine Technology:
Cached News: